Mission
Instead, Inc. Microbicides: Protecting the global population from HIV, other sexually-transmitted pathogens and unwanted pregnancy
Instead, Inc.’s research & development efforts are strongly focused in microbicide development. This is consistent with its corporate mission to provide women around the world with new and different healthy options for more freedom and control of their reproductive and sexual health.
Instead is a global leader in microbicide development. Instead owns worldwide rights to two microbicide products in development in this global quest for safe, affordable, woman-controlled protection against HIV, other sexually-transmitted pathogens and unwanted pregnancy.
Scientific research is underway at leading institutions around the world on both Amphora and BufferGel. Amphora was granted a 510k marketing clearance for use as a personal lubricant by the US FDA in June, 2004, becoming the only developmental microbicide with clearance for human use. |
